EVENITY (ROMOSOZUMAB-AQQG) — FDA Approval BLA761062 (AMGEN INC)
EVENITY (ROMOSOZUMAB-AQQG) — FDA Approval BLA761062 (AMGEN INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EVENITY; Active ingredients: ROMOSOZUMAB-AQQG; Application number: BLA761062.
| Brand name | EVENITY |
|---|---|
| Active ingredients | ROMOSOZUMAB-AQQG |
| Application number | BLA761062 |
| Sponsor | AMGEN INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20190409 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →